DEVELOPMENT AND IN VITRO EVALUATION OF 5-FLUOROURACIL NANOPARTICLES BY SALTING OUT TECHNIQUE

  • SAILAJA PB Department of , Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, India.
  • JEEVANA JYOTHI B Department of , Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, India.

Abstract

Objectives: At the current miserable state of the prevalence of cancers, there is a need for the development of simple technologies to prepare formulations of anticancer drugs with less economy and investment. Hence, the aim of the present work is to prepare nanoparticles of 5-fluorouracil (5-FU) by simple technique, such as salting out method.


Methods: Nanoparticles containing 10 mg of 5-FU were prepared by salting out method using Eudragit-100 as polymer. The prepared nanoparticles were evaluated by particle size, zeta potential, in vitro drug release studies, and drug-excipient interaction studies.


Results: Nanoparticles prepared by salting out methods showed higher dissolution rate for formulation F3 and F5 revealed high percentage release of 98.6±0.24 in 60 min and 86.5±0.39% in 120 min. Fourier transform infrared (FTIR) spectra revealed no interaction between drug and excipients used for preparation.


Conclusion: 5-FU nanoparticles can be produced successfully by salting out method using drug to polymer (Eudragit S-100) ratio of 1:3 to possess ideal drug release characteristics and average particle size of 205.1 nm.

Keywords: 5-Fluorouracil, Pancreatic cancer, Nanoparticles, Salting out method, Enhanced dissolution

Author Biography

JEEVANA JYOTHI B, Department of , Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, India.

professor

References

1. Tran S, DeGiovanni P, Piel B, Rai P. Cancer nanomedicine: A review of recent success in drug delivery. Clin Transl Med 2017;6:44.
2. Nasr M, Ghorab MK, Abdlazem A. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B 2015;5:79-88.
3. Tawfik E. Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity. Saudi Pharma J 2017;25:206-13.
4. Kavitha K, Rao SA, Nalini CN. An investigation on enhancement of solubility of 5 flourouracil by applying complexation technique-characterization, dissolution and molecular-modelling studies. J Appl Pharm Sci 2013;3:162-6.
5. Tummala S. Formulation and characterization of 5-fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer. Saudi Pharm J 2015;23:308-14.
6. Pridgen EM, Langer R, Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond) 2007;2:669-80.
7. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnology 2018;16:71.
8. Patel M, Patel NV, Patel TB. Design and development of rilpivirine nanoparticle containing chitosan using ionic gelation method for HIV infections. Int J Pharm Pharm Sci 2020;12:113-8.
9. Gopi G, Kannan K. Formulation development and optimization of nateglinide-loaded ethyl cellulose nanoparticles by Box-Behnken design. Int J Pharm Pharm Sci 2015;7:310-5.
10. Allemann E, Gurny R. Drug-loaded nanopratcles-preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993;39:173-91.
11. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004;21:1428-39.
Statistics
53 Views | 79 Downloads
Citatons
How to Cite
PB, S., and J. JYOTHI B. “DEVELOPMENT AND IN VITRO EVALUATION OF 5-FLUOROURACIL NANOPARTICLES BY SALTING OUT TECHNIQUE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 4, Feb. 2020, pp. 166-71, doi:10.22159/ajpcr.2020.v13i4.36967.
Section
Original Article(s)